Chumney, Elinor C.; Simpson, Kit N. - In: Disease Management and Health Outcomes 10 (2002) 4, pp. 229-232
The absence of government regulation in the US has left pharmaceutical companies free to set their own prices based on a number of market considerations. Historically, these have included not only ingredient, research and development costs, but also advertising, the drug's marginal...